Medtronic and DASI Simulations Partner to Advance the Future of TAVR Through Predictive Modeling and Personalized Planning
Partnership launches AI solution to enhance predictive heart valve visualization and personalize valve treatment planning decisions enabling the future of TAVR for structural heart patients
DUBLIN, Ohio, October 21, 2025 (Newswire.com) – Medtronic plc, a global leader in healthcare technology, and DASI Simulations, a leader in AI-driven predictive modeling and digital-twin technology, today announced a strategic partnership to enhance access to DASI technology to optimize outcomes for patients undergoing transcatheter aortic valve replacement (TAVR) in the United States.
This program marks a significant step forward in both Medtronic’s and DASI’s mission to deliver innovative, patient-specific care. By integrating DASI Simulations’ advanced AI-based predictive modeling and digital twin technology into the TAVR workflow, clinicians will gain access to independent and device-agnostic actionable insights that support more precise, individualized treatment decisions for patients living with aortic stenosis.
